Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/G1LP34 stock hub

BVMF/G1LP34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/G1LP34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.1B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/G1LP34

In the news

Latest news · BVMF/G1LP34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.3P50 14.6P75 19.6

Trailing P/E3.1

P25 15.2P50 21.5P75 27.3

ROE16.3

P25 5.3P50 12.3P75 22.5

ROIC241.3

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/G1LP34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

EUR

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BR
Employees	704
Enterprise value	BRL -8B
Exchange	Brazil Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 9.1B
Price	BRL 6.88
Price currency	BRL
Rev Per Employee	8,917,708.22x
Sector	Healthcare
Sic	2836
Symbol	bvmf/G1LP34
Website	https://lakefrontbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	32.22%
EV Earnings	-2.73x
EV/FCF	4.3x
FCF yield	-20.46%
P/B ratio	0.47x
P/E ratio	3.1x
P/S ratio	1.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	60.39%
EBITDA Margin	63.52%
Gross margin	53.99%
Gross Profit	BRL 3.4B
Gross Profit Growth Q	-97.25%
Net Income	BRL 2.9B
Pretax Margin	45.14%
Profit Margin	46.83%
Profit Per Employee	BRL 4.2M
ROA	10.65
Roa5y	0.27
ROCE	19.26
ROE	16.26
Roe5y	0.58
ROIC	241.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11%
Cagr3y	-10.6%
Revenue Growth	262.17x
Revenue Growth Q	-91.36x
Revenue Growth3 Y	85.52x
Revenue Growth5 Y	16.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.28
Assets	BRL 20.3B
Cash	BRL 17.9B
Current Assets	BRL 17.7B
Current Liabilities	BRL 582M
Debt	BRL 38.7M
Debt EBITDA	BRL 0.01
Debt Equity	BRL 0
Debt FCF	BRL -0.02
Equity	BRL 19.6B
Interest Coverage	1,612
Liabilities	BRL 716.1M
Long Term Assets	BRL 2.5B
Long Term Liabilities	BRL 134.1M
Net Cash	BRL 17.9B
Net Cash By Market Cap	BRL 196
Net Cash Growth	-9.45%
Net Debt EBITDA	BRL -4.49
Net Debt Equity	BRL -0.91
Tangible Book Value	BRL 19.6B
Tangible Book Value Per Share	BRL 297
WACC	4.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	30.48
Inventory Turnover	17.09
Net Working Capital	BRL -122.4M
Quick ratio	30.23
Working Capital	BRL 17.8B
Working Capital Turnover	BRL 2.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11%
200-day SMA	8.42
3Y total return	-28.56%
50-day SMA	8.11
50-day SMA vs 200-day SMA	50under200
All Time High	13.42
All Time High Change	-48.73%
All Time High Date	2022-09-12
All Time Low	6.46
All Time Low Change	6.5%
All Time Low Date	2024-08-19
ATR	0.11
Beta	0.12
Ch YTD	-25.05
High	6.88
High52	10
High52 Date	2025-10-03
High52ch	-31.2%
Low	6.86
Low52	6.86
Low52 Date	2026-05-07
Low52ch	0.29%
Ma50ch	-15.19%
Price vs 200-day SMA	-18.26%
RSI	22.47
RSI Monthly	40.08
RSI Weekly	29.96
Sharpe ratio	0.04x
Sortino ratio	0.21
Total Return	-0.03%
Tr YTD	-25.05
Tr1m	-10.42%
Tr1w	-3.23%
Tr3m	-21.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 3.8B
Operating margin	60.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,538,448%
Net Borrowing	-16,064,590.6
Shares Insiders	0.02%
Shares Institutions	33.12%
Shares Qo Q	-0.07%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL -2B
Average Volume	16.95x
Bv Per Share	297.1
CAPEX	BRL -52.5M
Ch1m	-10.42
Ch1w	-3.23
Ch1y	-11
Ch3m	-21.55
Ch3y	-28.56
Ch6m	-14.11
Change	-3.23%
Change From Open	0.29
Close	7.11
Days Gap	-3.52
Depreciation Amortization	189,352,958.9
Dollar Volume	385.3
Earnings Date	2026-05-06
EBIT	BRL 3.8B
EBITDA	BRL 4B
EPS	BRL 44.61
F Score	5
FCF	BRL -1.9B
FCF EV Yield	23.25x
Financing CF	-16,673,310
Fiscal Year End	December
Founded	1,999
Graham Number	27.12835
Graham Upside	294.3
Income Tax	BRL -100.7M
Investing CF	1,597,353,616
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	8.58
Ma150ch	-19.78%
Ma20	7.32
Ma20ch	-5.97%
Net CF	-248,186,910
Next Earnings Date	2026-08-10
Open	6.86
Position In Range	100
Ppne	445,948,863.3
Price Date	2026-05-07
Price EBITDA	BRL 2.29
Ptbv Ratio	0.47
Relative Volume	3.3x
Revenue	6,278,066,588x
SBC By Revenue	2.3x
Share Based Comp	144,351,647
Tax By Revenue	-1.6x
Tr6m	-14.11%
Volume	56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/G1LP34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/G1LP34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/G1LP34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.1%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

BVMF/G1LP34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

22.5

Below 30: short-term oversold

Price vs 200-day MA

-18.3%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/G1LP34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/G1LP34 stock rating?

bvmf/G1LP34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/G1LP34 analysis?

The full report lives at /stocks/bvmf/G1LP34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/G1LP34?

The latest report frames bvmf/G1LP34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/G1LP34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.